Centene Corp is a leading healthcare enterprise that specializes in providing a range of services designed to enhance the quality, accessibility, and affordability of healthcare for individuals and families, particularly those in underserved communities. The company primarily operates within the managed care sector, offering government-sponsored healthcare programs such as Medicaid and Medicare, as well as health insurance marketplace offerings. Centene's commitment to addressing the diverse needs of its members is underscored by its focus on innovative care models, integrated services, and a dedication to improving health outcomes through personalized support and a deep understanding of local health systems. Read More
NVDA stock hit a $4 trillion market cap, but tariff concerns brought back the bears; next week brings a slew of economic data and the start of earnings season
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Centene Corporation (“Centene”) (NYSE: CNC) on behalf of those who purchased or otherwise acquired Centene securities between December 12, 2024, and June 30, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is September 8, 2025.
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Centene Corporation (“Centene” or the “Company”) (NYSE: CNC) securities between December 12, 2024 to June 30, 2025, inclusive (the “Class Period”). Centene investors have until September 8, 2025 to file a lead plaintiff motion.
NEW YORK - July 11, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Centene Corporation (NYSE: CNC) of a class action securities lawsuit.
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Centene To Contact Him Directly To Discuss Their Options
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Centene Corporation (“Centene” or the “Company”) (NYSE: CNC) securities between December 12, 2024 to June 30, 2025, inclusive (the “Class Period”). Centene investors have until September 8, 2025 to file a lead plaintiff motion.
Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Centene Corporation (NYSE: CNC) and certain of the Company’s senior executives for potential violations of the federal securities laws.
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Centene Corporation (“Centene” or the “Company”) (NYSE: CNC) between December 12, 2024 and June 30, 2025, inclusive.
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Centene Corporation (“Centene” or the “Company”) (NYSE: CNC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
The law firm of Robbins Geller Rudman & Dowd LLP announces that the Centene class action lawsuit seeks to represent purchasers or acquirers of Centene Corporation (NYSE: CNC) securities between December 12, 2024 and June 30, 2025, inclusive (the “Class Period”). Captioned Lunstrum v. Centene Corporation, No. 25-cv-05659 (S.D.N.Y.), the Centene class action lawsuit charges Centene and certain of Centene’s top executives with violations of the Securities Exchange Act of 1934.
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Centene Corporation (“Centene” or “the Company”) (NYSE: CNC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
NEW YORK, July 09, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Centene Corporation (“Centene” or the “Company”) (NYSE:CNC) in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased or otherwise acquired Centene securities between December 12, 2024 to June 30, 2025, both dates inclusive (the “Class Period”). Investors have until September 8, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
Centene just crashed. But, price target updates signal the selloff is overdone, with 50% upside in play. However, the "Big Beautiful Bill" is another curveball.
NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Centene Corporation (“Centene” or the “Company”) (NYSE:CNC) on behalf of Centene stockholders. Our investigation concerns whether Centene has violated the federal securities laws and/or engaged in other unlawful business practices.
UnitedHealth, Centene, and Elevance suffered steep market cap losses amid earnings guidance withdrawals and potential Medicaid changes tied to new legislation.
NEW YORK, July 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Centene Corporation (“Centene” or the “Company”) (NYSE: CNC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
